Snowflake director exercises options, sells 55,350 shares
Snowflake Inc. director Frank Slootman reported a pre‑planned option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Snowflake Inc. director Frank Slootman reported a pre‑planned option exercise and share sale. On May 26, 2026, he exercised stock options to acquire 55,350 shares of Snowflake common stock at an exercise price of $8.88 per share and sold 55,350 shares in open‑market transactions at weighted‑average prices in the mid‑$170s, all pursuant to a Rule 10b5‑1 trading plan adopted on September 19, 2025. Following these transactions, he continues to hold Snowflake shares indirectly through several family trusts and retains 6,336,655 stock options that remain outstanding and fully vested.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 55,350 | $0.00 | $0.00 |
| Exercise | Common Stock | 55,350 | $8.88 | $492K |
| Sale | Common Stock | 19,077 | $175.466 | $3.35M |
| Sale | Common Stock | 14,174 | $176.419 | $2.50M |
| Sale | Common Stock | 22,099 | $177.498 | $3.92M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. The exercise and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $175.000 to $175.965, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $176.000 to $176.870, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $177.135 to $178.080, inclusive.
- F6. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F7. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F8. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F9. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F10. The stock option is fully vested.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Grantor Retained Annuity Trust financial
restricted stock units financial
weighted-average price financial
Stock Option (Right to Buy) financial
fully vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Snowflake (SNOW) director Frank Slootman report in this Form 4?
What stock options did Frank Slootman exercise in Snowflake (SNOW)?
Does Frank Slootman still hold Snowflake (SNOW) stock options after this Form 4?
Were Frank Slootman’s Snowflake (SNOW) transactions made under a Rule 10b5-1 plan?
What indirect Snowflake (SNOW) holdings are reported for Frank Slootman?
AI-generated analysis. How Rhea-AI works. Not financial advice.